Elixxer Ltd Total Liabilities

Latest as of September 2025: CA$17.22 Million CAD ≈ $12.46 Million USD

Elixxer Ltd total liabilities. Based on the latest financial reports, Elixxer Ltd (ELXR) has total liabilities worth CA$17.22 Million CAD (≈ $12.46 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how many days can Elixxer Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Elixxer Ltd (2017–2024)

Total liabilities of Elixxer Ltd from 2017 to 2024. This chart illustrates how Elixxer Ltd's total liabilities have evolved over time, based on quarterly financial data. Check ELXR asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Elixxer Ltd Competitors by Total Liabilities

The table below lists competitors of Elixxer Ltd ranked by their total liabilities.

Company Country Total Liabilities
TTA Holdings Ltd
AU:TTA
Australia AU$594.78K
Tongaat
JSE:TON
South Africa ZAC7.30 Billion
Renalytix AI plc
LSE:RENX
UK GBX12.81 Million
Multistack International Ltd
AU:MSI
Australia AU$2.90 Million
M Winkworth PLC
LSE:WINK
UK GBX1.83 Million
Altair Resources Inc
V:AVX
Canada CA$3.11 Million
Annum Bhd
KLSE:5082
Malaysia RM20.48 Million
Eden Research plc
LSE:EDEN
UK GBX2.85 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Elixxer Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Elixxer Ltd (ELXR) total assets.

Liquidity & Leverage Metrics

Elixxer Ltd Total Liabilities Ratios Explained

Elixxer Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.01 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.14 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 7.93 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Elixxer Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Elixxer Ltd (2017–2024)

The table below shows the annual total liabilities of Elixxer Ltd from 2017 to 2024.

Year Total Liabilities Change
2024-12-31 CA$15.23 Million
≈ $11.02 Million
+22.72%
2023-12-31 CA$12.41 Million
≈ $8.98 Million
+13.29%
2022-12-31 CA$10.95 Million
≈ $7.92 Million
+29.54%
2021-12-31 CA$8.45 Million
≈ $6.12 Million
-47.34%
2020-12-31 CA$16.06 Million
≈ $11.61 Million
+424.04%
2018-12-31 CA$3.06 Million
≈ $2.22 Million
+161.66%
2017-12-31 CA$1.17 Million
≈ $847.04K
--

About Elixxer Ltd

V:ELXR Canada Drug Manufacturers - Specialty & Generic
Market Cap
$287.08K
CA$396.86K CAD
Market Cap Rank
#31266 Global
#1666 in Canada
Share Price
CA$0.04
Change (1 day)
+0.00%
52-Week Range
CA$0.03 - CA$1.15
All Time High
CA$99.00
About

Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Mon… Read more